In our clinical biofluid samples, the loss of phosphorylation of Rab29 in urine exosomes from iPD and A53T-PD patients, releasing its inhibition, would be consistent with increased activation of LRRK2 (e.g. increased pT73-Rab10 in the iPD group). The gene discussed is LRRK2; the disease is Parkinson disease.